Top Industry Leaders in the Pacemaker Market
Abbott (US) Launched its Aveir DR system in June 2023, the first commercially available dual-chamber leadless pacemaker in the US. This development marks a significant step towards leadless technology becoming mainstream.
Medtronic (US) Received FDA approval for its Micra AV2 dual-chamber leadless pacemaker in May 2023, further expanding its portfolio of leadless technology options.
Boston Scientific (US) Announced plans to launch its EnRhythm™ MRI conditional dual-chamber leadless pacemaker in Europe in October 2023, aiming to broaden availability of MRI-compatible options.
Livita Medical (Canada) Received CE Mark approval for its S-ICD® subcutaneous defibrillator system in July 2023, offering an alternative to traditional implantable defibrillators for some patients with arrhythmias. This technology may provide a less invasive option for specific cases.
Micropace (US) Announced a strategic partnership with Biotronik (Germany) in August 2023 to collaborate on the development and commercialization of next-generation pacemaker technologies. This collaboration combines expertise for potential future advancements.
List of Pacemaker Key Companies in the Market
-
Medtronic (Dublin Ireland)
-
Abbott Laboratories (US)
-
Boston Scientific (US)
-
Biotronik (Germany)
-
Livanova (UK)
-
Lepu Medical (China)
-
Shree Pacetronix (India)
-
Osypka Medical (Germany
-
Medico Spa (Italy)
-
Oscor (US)